Ask Warren

Qurient

115180 · KOSDAQ · ₩115180 · 큐리언트

₩17,830▼ ₩140 (0.78%)End-of-day · Oct 29, 2026 · End-of-day prices.
Trade
Alert me
SellBuy

Filings

  • Ex-Rights Date (Rights Offering)권리락 (유상증자)

    Predicted impact: Medium

    Ex-rights date for a rights offering already detailed in earlier filings; mechanical price adjustment.

    Oct 16, 2026Open on DART
  • Determination of Issue Price for First Tranche of Rights Offering유상증자1차발행가액결정

    Predicted impact: Medium· Actual: −8.9% vs sector, volume 1.1× normal (5 trading days)

    First issue price set for rights offering already disclosed in recent filings; size vs shares unknown, so lowered one level.

    Oct 16, 2026Open on DART
  • Prospectus투자설명서

    Predicted impact: Low· Actual: −11.6% vs sector, volume 0.9× normal (5 trading days)

    Oct 16, 2026Open on DART
  • Terms set: Securities registration statement[발행조건확정]증권신고서(지분증권)

    Predicted impact: Low· Actual: −8.9% vs sector, volume 1.1× normal (5 trading days)

    Equity securities registration statement declared effective; share count and size unknown, so impact on shares cannot be gauged.

    Oct 16, 2026Open on DART
  • Amended: Rights offering (paid-in capital increase) decision[기재정정]주요사항보고서(유상증자결정)

    Predicted impact: Low· Actual: −8.9% vs sector, volume 1.1× normal (5 trading days)

    Oct 16, 2026Open on DART
  • Securities registration statement효력발생안내( 2026.9.29. 제출 증권신고서(지분증권) )

    Predicted impact: Medium· Actual: −8.9% vs sector, volume 1.1× normal (5 trading days)

    Equity securities registration statement declared effective; share count and size unknown, so impact on shares cannot be gauged.

    Oct 16, 2026Open on DART
  • Trading Plan Report for Executives and Major Shareholders' Specific Securities임원ㆍ주요주주특정증권등거래계획보고서

    Predicted impact: Low· Actual: −8.9% vs sector, volume 1.1× normal (5 trading days)

    Oct 15, 2026Open on DART
  • Investor relations (IR) event기업설명회(IR)개최

    Predicted impact: Low· Actual: −18.6% vs sector, volume 2.4× normal (5 trading days)

    Oct 13, 2026Open on DART
  • Amended: Securities registration statement[기재정정]증권신고서(지분증권)Sep 29, 2026Open on DART
  • Amended: Rights offering (paid-in capital increase) decision[기재정정]주요사항보고서(유상증자결정)Sep 29, 2026Open on DART
  • Investor relations (IR) event기업설명회(IR)개최Sep 22, 2026Open on DART
  • Investor relations (IR) event기업설명회(IR)개최Sep 22, 2026Open on DART
  • Securities registration statement정정신고서제출요구( 2026.09.04. 제출 증권신고서(지분증권) )Sep 17, 2026Open on DART
  • Investor relations (IR) event기업설명회(IR)개최Sep 7, 2026Open on DART
  • Investor relations (IR) event기업설명회(IR)개최Sep 4, 2026Open on DART
  • Securities registration statement[정정제출요구]증권신고서(지분증권)Sep 4, 2026Open on DART
  • Rights offering (paid-in capital increase) decision주요사항보고서(유상증자결정)Sep 4, 2026Open on DART
  • Amended: Major management matter relevant to investors[기재정정]투자판단관련주요경영사항(임상시험계획승인신청등결정) (만성 이식편대숙주질환 환자 대상 Q702 단독치료요법의 스페인 임상 제1b상 임상시험계획 승인)Aug 18, 2026Open on DART
  • Half-year report (Jun 2026)반기보고서 (2026.06)Aug 14, 2026Open on DART
  • 5%+ holding report주식등의대량보유상황보고서(일반)Aug 5, 2026Open on DART
  • 5%+ holding report주식등의대량보유상황보고서(일반)Aug 4, 2026Open on DART
  • Insider shareholding report임원ㆍ주요주주특정증권등소유상황보고서Jul 30, 2026Open on DART
  • 5%+ holding report주식등의대량보유상황보고서(일반)Jul 27, 2026Open on DART
  • 5%+ holding report주식등의대량보유상황보고서(일반)Jul 24, 2026Open on DART
  • 5%+ holding report주식등의대량보유상황보고서(일반)Jun 23, 2026Open on DART
  • 5%+ holding report주식등의대량보유상황보고서(일반)Jun 22, 2026Open on DART
  • [Amended] Exercise of Stock Purchase Options[기재정정]주식매수선택권행사May 21, 2026Open on DART
  • Quarterly report (Mar 2026)분기보고서 (2026.03)May 15, 2026Open on DART
  • Exercise of Stock Purchase Options주식매수선택권행사Apr 30, 2026Open on DART
  • Insider shareholding report임원ㆍ주요주주특정증권등소유상황보고서Apr 30, 2026Open on DART
  • Insider shareholding report임원ㆍ주요주주특정증권등소유상황보고서Apr 30, 2026Open on DART
  • Insider shareholding report임원ㆍ주요주주특정증권등소유상황보고서Apr 30, 2026Open on DART
  • Insider shareholding report임원ㆍ주요주주특정증권등소유상황보고서Apr 30, 2026Open on DART
  • Insider shareholding report임원ㆍ주요주주특정증권등소유상황보고서Apr 3, 2026Open on DART
  • Insider shareholding report임원ㆍ주요주주특정증권등소유상황보고서Mar 31, 2026Open on DART
  • Insider shareholding report임원ㆍ주요주주특정증권등소유상황보고서Mar 31, 2026Open on DART
  • Annual general meeting results정기주주총회결과Mar 26, 2026Open on DART
  • Notice on Grant of Stock Purchase Options주식매수선택권부여에관한신고Mar 26, 2026Open on DART
  • Audit report submitted감사보고서제출Mar 18, 2026Open on DART
  • Amended: Audit report submitted[기재정정]감사보고서제출 (2024 사업연도)Mar 18, 2026Open on DART
  • Amended: Audit report submitted[기재정정]감사보고서제출 (2023 사업연도)Mar 18, 2026Open on DART
  • Annual report (Dec 2025)사업보고서 (2025.12)Mar 18, 2026Open on DART
  • Amended: Annual report (Dec 2024)[기재정정]사업보고서 (2024.12)Mar 18, 2026Open on DART
  • Amended: Annual report (Dec 2023)[기재정정]사업보고서 (2023.12)Mar 18, 2026Open on DART
  • Shareholders' meeting called주주총회소집결의Mar 11, 2026Open on DART
  • [Amendment] Occurrence of Derivative Trading Loss[기재정정]파생상품거래손실발생Mar 11, 2026Open on DART
  • [Amended] Change of 30% or More in Sales or Profit Structure (15% or More for Large Companies)[기재정정]매출액또는손익구조30%(대규모법인은15%)이상변동Mar 11, 2026Open on DART
  • Reference Document for Proxy Solicitation of Voting Rights의결권대리행사권유참고서류Mar 11, 2026Open on DART
  • Notice of shareholders' meeting주주총회소집공고Mar 11, 2026Open on DART
  • 5%+ holding report주식등의대량보유상황보고서(일반)Mar 3, 2026Open on DART

Titles in Korean until English translations are added.

Also known as: Qurient / 큐리언트 / 115180 / KRX:115180

Source: KRX statistical information